Not So Different: a Podcast from The Center for Biosimilars
Not So Different: A Podcast from The Center for Biosimilars
"Not So Different," a podcast from The Center for Biosimilars, brings you expert viewpoints from physicians, pharmacists, patients, developers, and other stakeholders in the complex world of biosimilar therapies.
Δημιουργός
Not So Different: a Podcast from The Center for Biosimilars
Κατηγορία
Ιστοσελίδα του podcast
Τελευταίο επεισόδιο
30 Νοε 2025
Πού να ακούσεις;
Podcast στην εφαρμογή Replaio Radio Έρχεται σύντομαΤα podcast έρχονται σύντομα στην εφαρμογή. Εγκατάστησέ την τώρα και δες πρώτος μια εντελώς νέα προσέγγιση στα podcast
Δωρεάν εγκατάσταση
Android σχεδόν 10 εκατ. λήψεις · βαθμολογία 4,8
iOS σύντομα
Επεισόδια
S4 Ep9: Dr Juliette Petit: How Nurses Prevent Nocebo Effect in Biosimilar Switching 28.03.2021 11:50
Learn more about Dr Petit’s study .
S4 Ep8: Minnesota Legislator Discusses Bill to Broaden Biosimilar Coverage 14.03.2021 10:52
To learn more about the bill, click here . To read the bill’s official text, click here . To learn more about payer formulary preferences, click here .
S4 Ep7: Goodwin Attorneys Discuss Updates to Biosimilars Litigation Guide 07.03.2021 11:11
To learn more about Valenti and Cerwicki's updated guide, click here . To learn more about adalimumab patent disputes, click here . To learn more about the future state for the adalimumab market, click here . To take our quiz on adalimumab, click here .
S4 Ep6: Anar Dossa Discusses Success and Savings With British Columbia’s Biosimilars Initiative 28.02.2021 12:23
To learn more about phase 3 of the BC Biosimilars Initiative, click here . To learn more about recent biosimilar launches in Canada, click here or here . To learn more about biosimilar switches in Canada, click here . To learn more about other Canadian province’s biosimilar plans, click here . To learn more about Pacific Blue Cross’s success with the program, click here .
S4 Ep5: Sarfaraz Niazi, PhD Discusses Market Projections For High-Concentration Adalimumab Biosimilars 21.02.2021 13:20
To learn more about Celltrion's EU approval, click here . To learn more about Alvotech’s high concentration adalimumab, click here . To learn more about high-concentration citrate-free adalimumab products, click here . To learn about the patent dance, click here . For more in adalimumab news, click here or here .
S4 Ep4: Steven Lucio Discusses BI’s Citizen Petition and the Current Status of Biosimilars 14.02.2021 12:45
To learn more about BI’s citizen petition, click here . To hear more from Steven Lucio, PharmD, BCPS, click here . To learn more about Vizient, click here .
S4 Ep3: The Race to the Top: Does China Have What it Takes? 07.02.2021 5:00
You can read more about China’s market by clicking here or here . For information on Bio-Thera, click here . For information on Shanghai Henlius Biotech, click here .
S4 Ep2: Why You Should Keep Your Eye on Ophthalmology Biosimilars 24.01.2021 7:57
To read more on Dr Oskouei's contributor piece, click here .
S4 Ep1: Charles Bennett, MD, PhD, Discusses Why the FTC Needs to Join the Effort to Improve the Biosimilar Market 10.01.2021 9:29
To read more about Bennett's study, click here .
S3 Ep32: Sean McGowan on What’s in Store for Biosimilars in 2021 and Beyond 06.12.2020 10:41
To watch the full first part of this interview, click here . To watch part 2 of this interview, click here . To watch part 3 of this interview, click here .
S3 Ep31: A Trio of Experts’ Take on What Needs to Change to Boost Biosimilar Adoption 29.11.2020 8:57
To learn more about biosimilar barriers, click here . To learn more about the US Oncology Network, click here . To learn more about McKesson, click here .
S3 Ep30: Kathy Oubre On What Practices Can Learn About the Benefits of Implementing Biosimilars 15.11.2020 9:09
To learn more about the COA's virtual Payer Exchange Summit on Oncology Payment Reform, click here . To learn more about Pontchartrain Cancer Center, click here .
S3 Ep29: Steven C. Hill, PhD, Discusses Rebates and Specialty Drug Spending 08.11.2020 12:26
To learn more about this study, click here .
S3 Ep28: Nancy Globus, PharmD, on Whether Comparative Efficacy Trials are Necessary 25.10.2020 7:46
To learn more about the study mentioned in this podcast, click here . To learn more about the United Kingdom's stance on comparative efficacy trials, click here .
S3 Ep27: Kathy Oubre on What Oncology Practices Lacked During the Pandemic 18.10.2020 14:17
To learn more about COVID-19’s impact on biosimilars, check out our ebook here .
S3 Ep26: Kanika Monga, MD, and Angus Worthing, MD, Discuss ACR Survey on Biosimilars and COVID-19 11.10.2020 12:09
To learn more about the ACR’s survey, click here . To learn more about COVID-19’s impact on biosimilars, check out our ebook here .
S3 Ep25: Wayne Winegarden, PhD, On Why Importing Drugs From Canada Is a Bad Idea 04.10.2020 8:59
To read more on Wayne’s thoughts of this plan, click here . To learn more about the Safe Importation Action Plan, click here . To learn more about President Trump’s executive orders, click here .
S3 Ep24: Julie Kennerly-Shah, PharmD, on How Biosimilars Can Help Curb COVID-19's Impact 27.09.2020 10:55
To learn more about COVID-19's impact on biosimilars, click here . To learn more about biosimilar education, click here . To learn more about step therapy, click here . To learn more about payer interference on preferred drugs, click here .
S3 Ep23: Rep Grothman on His Bill to Make Biosimilar Insulins Interchangeable 20.09.2020 9:03
To learn more about HR 8190, click here . To learn more about the regulatory transition of insulin under the BPCIA, click here . To learn more about interchangeability designations, click here .
S3 Ep22: Alex Moulson on How Companies Choose Which Biosimilars to Produce 13.09.2020 9:54
To check out more of our coverage of Polpharma Biologics, click here . To learn more about Polpharma's natalizumab clinical trial, click here . To learn about Polpharma Biologics recent integration efforts, click here . To learn more about Polpharma Biologics, click here .
S3 Ep21: Cheryl Larson on How Employers Can Get Biosimilars Added to Their Health Plan 06.09.2020 10:37
To learn more about MBGH's call to action for employers, click here . To learn more about MBGH's biosimilars report, click here . To learn more about Midwest Business Group on Health, click here .
S3 Ep20: Jonathan Sweeting on Aybintio's European Approval 30.08.2020 9:14
To learn more about the EC's approval of Aybintio, click here . To learn more about Samsung Bioepis, click here .
S3 Ep19: Nancy Globus, PharmD, on the Effect of Biosimilar Suffixes 23.08.2020 6:14
To learn more about biosimilar naming, click here . Click here to learn more about the ACMA.
S3 Ep18: Carter Thorne, MD, Discusses Biosimilar Switching in Canada 16.08.2020 7:54
To learn more about Canadian switching policies, click here .
S3 Ep17: Sizing Up European Biosimilar Competition 09.08.2020 9:32
To check out the scorecard, click here . To learn more about Medicines for Europe, click here .
Παρόμοια podcast
Άκου το podcast Not So Different: A Podcast from The Center for Biosimilars στο Replaio
Ραδιόφωνο και podcast σε μία εφαρμογή - δωρεάν, χωρίς εγγραφή. Εγκατάστησέ την σήμερα και μη χάσεις την πρεμιέρα
Το Replaio δεν είναι εκδότης podcast - τα ονόματα των εκπομπών, τα εξώφυλλα και ο ήχος ανήκουν στους δημιουργούς τους και διανέμονται μέσω δημόσιων ροών RSS
